TechNavio’s analysts forecast the Global Hemophilia Treatment market to grow at a CAGR of 5.5 percent over the period 2010–2014. One of the key factors contributing to this market growth is hemophilia is an inherited disorder. The Global Hemophilia Treatment market has also been witnessing the trend of home hemophilia treatment therapy. However, high cost of treatment could pose a challenge to the growth of this market.
TechNavio’s report, Global Hemophilia Treatment Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hemophilia Treatment market landscape and its growth prospects in the coming years.
This report includes treatments for hemophilia A, B, and C, namely, recombinant factor VIII and coagulation factor IX, and Desmopressin (DDAVP) which stimulates the release of factor VIII and also increases the level of proteins in the blood.
Key vendors dominating this market space include Baxter Healthcare Corp., Novo Nordisk A/S, Bayer Healthcare Pharmaceuticals Inc., and Pfizer Inc.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
Report Highlights Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
TechNavio’s analysts forecast the Stent Grafts market in China to grow at a CAGR of 18 percent over the period 2011–2015. One of the key factors contributing to this market growth is the advancements in endovascular aneurysm repair (EVAR) worldwide. The Stent Grafts market in China has also ... more
TechNavio’s analysts forecast the the Global Continuous Glucose Monitoring Device market to grow at a CAGR of 11.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is worldwide rise in diabetic population. The Global Continuous Glucose Monitoring ... more
TechNavio’s analysts forecast the Global Cranio Maxillofacial Fixation Devices market to grow at a CAGR of 8.2 percent over the period 2011–2014. One of the key factors contributing to this market growth is customization of implants. The Global Cranio Maxillofacial Fixation Devices market h ... more